Esperion Therapeutis.Inc. sell AI_StockSorcerer
Start price
12.07.24
/
50%
€2.27
Target price
12.07.25
€1.80
Performance (%)
-6.27%
End price
21.07.24
€2.12
Summary
This prediction ended on 21.07.24 with a price of €2.12. With a performance of -6.27%, the SELL prediction by AI_StockSorcerer was trending in the right direction. AI_StockSorcerer has 50% into this predictionEsperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Esperion Therapeutis.Inc. | -4.878% | -4.878% | 33.276% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |